1. Axelrad JE, Cadwell KH, Colombel JF, Shah SC. The role of gastrointestinal pathogens in inflammatory bowel disease: a systematic review. Therap Adv Gastroenterol. 2021 Mar; 14: 17562848211004493. doi: 10.1177/17562848211004493. [ DOI] [ PubMed] 2. Matsuoka K, Kobayashi T, Ueno F, Matsui T, Hirai F, Inoue N, et al. Evidence-based clinical practice guidelines for inflammatory bowel disease. J Gastroenterol. 2018 Mar; 53(3): 305-53. doi: 10.1007/s00535-018-1439-1. [ DOI] [ PubMed] 3. Tavakoli P, Vollmer-Conna U, Hadzi-Pavlovic D, Grimm MC. A Review of Inflammatory Bowel Disease: A Model of Microbial, Immune and Neuropsychological Integration. Public Health Rev. 2021 May; 42: 1603990. doi: 10.3389/phrs.2021.1603990. [ DOI] [ PubMed] 4. Khaki-Khatibi F, Qujeq D, Kashifard M, Moein S, Maniati M, Vaghari-Tabari M. Calprotectin in inflammatory bowel disease. Clin Chim Acta. 2020 Nov; 510: 556-65. doi: 10.1016/j.cca.2020.08.025. [ DOI] [ PubMed] 5. Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019 Dec; 68(Suppl 3): s1-s106. doi: 10.1136/gutjnl-2019-318484. [ DOI] [ PubMed] 6. Lężyk-Ciemniak E, Tworkiewicz M, Wilczyńska D, Szaflarska-Popławska A, Krogulska A. Usefulness of Testing for Fecal Calprotectin in Pediatric Gastroenterology Clinical Practice. Med Princ Pract. 2021; 30(4): 311-19. doi: 10.1159/000512631. [ DOI] [ PubMed] 7. Jukic A, Bakiri L, Wagner EF, Tilg H, Adolph TE. Calprotectin: from biomarker to biological function. Gut. 2021 Oct; 70(10): 1978-88. doi: 10.1136/gutjnl-2021-324855. [ DOI] [ PubMed] 8. Rokkas T, Portincasa P, Koutroubakis IE. Fecal calprotectin in assessing inflammatory bowel disease endoscopic activity: a diagnostic accuracy meta-analysis. J Gastrointestin Liver Dis. 2018 Sep; 27(3): 299-306. doi: 10.15403/jgld.2014.1121.273.pti. [ DOI] [ PubMed] 9. Fukunaga S, Kuwaki K, Mitsuyama K, Takedatsu H, Yoshioka S, Yamasaki H, et al. Detection of calprotectin in inflammatory bowel disease: Fecal and serum levels and immunohistochemical localization. Int J Mol Med. 2018 Jan; 41(1): 107-18. doi: 10.3892/ijmm.2017.3244. [ DOI] [ PubMed] 10. Smith LA, Gaya DR. Utility of faecal calprotectin analysis in adult inflammatory bowel disease. World J Gastroenterol. 2012 Dec; 18(46): 6782-89. doi: 10.3748/wjg.v18.i46.6782. [ DOI] [ PubMed] 11. Lin JF, Chen JM, Zuo JH, Yu A, Xiao ZJ, Deng FH, et al. Meta-analysis: fecal calprotectin for assessment of inflammatory bowel disease activity. Inflamm Bowel Dis. 2014 Aug; 20(8): 1407-15. doi: 10.1097/MIB.0000000000000057. [ DOI] [ PubMed] 12. Mosli MH, Zou G, Garg SK, Feagan SG, MacDonald JK, Chande N, et al. C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2015 Jun; 110(6): 802-19. doi: 10.1038/ajg.2015.120. [ DOI] [ PubMed] 13. Kawashima K, Ishihara S, Yuki T, Fukuba N, Oshima N, Kazumori H, et al. Fecal calprotectin level correlated with both endoscopic severity and disease extent in ulcerative colitis. BMC Gastroenterol. 2016 Apr; 16: 47. doi: 10.1186/s12876-016-0462-z. [ DOI] [ PubMed] 14. Fu Y, Wang L, Xie C, Zou K, Tu L, Yan W, et al. Comparison of non-invasive biomarkers faecal BAFF, calprotectin and FOBT in discriminating IBS from IBD and evaluation of intestinal inflammation. Sci Rep. 2017 Jun; 7(1): 2669. doi: 10.1038/s41598-017-02835-5. [ DOI] [ PubMed] 15. Mak WY, Buisson A, Andersen MJ Jr, Lei D, Pekow J, Cohen RD, et al. Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis. Dig Dis Sci. 2018 May; 63(5): 1294-301. doi: 10.1007/s10620-018-4980-0. [ DOI] [ PubMed] 16. Buisson A, Mak WY, Andersen MJ, Lei D, Kahn SA, Pekow J, et al. Faecal Calprotectin Is a Very Reliable Tool to Predict and Monitor the Risk of Relapse After Therapeutic De-escalation in Patients With Inflammatory Bowel Diseases. J Crohns Colitis. 2019 Aug; 13(8): 1012-24. doi: 10.1093/ecco-jcc/jjz023. [ DOI] [ PubMed] 17. Freeman K, Taylor-Phillips S, Willis BH, Ryan R, Clarke A. Test accuracy of faecal calprotectin for inflammatory bowel disease in UK primary care: a retrospective cohort study of the IMRD-UK data. BMJ Open. 2021 Feb; 11(2): e044177. doi: 10.1136/bmjopen-2020-044177. [ DOI] [ PubMed] |
